**For years, Thirumalai Chemicals (TCL) was known as a dependable, low-cost producer of critical industrial and food-grade chemicals.**  
But today, the company stands at a **crossroads**: short-term financial pain, heavy capex, and global oversupply  yet with powerful long-term drivers quietly taking shape underneath.

This article explains **what the company really does**, **why it is struggling now**, and **where the opportunity may open up for long-term investors**, using the firm’s Annual Report 2024–25, its Q1 FY26 investor presentation, and its latest quarterly results.

# 1 What the Company Actually Does 

Think of Thirumalai Chemicals as a company that makes “invisible but essential” molecules  the building blocks used by several industries.

# Its core products serve four major sectors:

1. **Plastics & resins** – used in pipes, paints, coatings, and construction materials.
2. **Food & beverages** – souring agents, flavour enhancers, stabilisers.
3. **Pharmaceuticals** – active ingredients and intermediates.
4. **Specialty chemicals** – perfumes, cosmetics, adhesives, coatings.

TCL’s main chemicals are:

|Chemical|Where it is used|TCL’s standing|
|:-|:-|:-|
|**Phthalic Anhydride (PA)**|plasticisers, paints, dyes, UPR resins|**Top 3 globally**|
|**Maleic Anhydride (MAN)**|coatings, agriculture, food acids|Largest in SE Asia |
|**Fumaric & Malic Acid**|bakery, flavouring, pharma|Largest in India, SE Asia; only Malic producer in SE Asia |
|**Diethyl Phthalate (DEP)**|perfumes, cosmetics, repellents|High-quality niche offering|

# Where these products are made:

* **Ranipet, Tamil Nadu**  legacy integrated plant since 1973.
* **Dahej, Gujarat**  India’s largest single-train PA unit; recently expanded.
* **Malaysia subsidiary**  Maleic Anhydride; currently troubled.
* **USA (West Virginia)** brand-new advanced plant (commissioning soon).

These plants are built around one clear advantage: **extreme efficiency**.  
The company recovers **94% of its energy from internal waste heat**, meaning it can survive downturns better than competitors.

The last two years have been hard for almost every chemical company in Asia  but TCL’s pain has been deeper because of **three simultaneous storms**.

# Storm 1: China created massive oversupply.

The Chairman writes that Chinese manufacturers built **huge capacities far beyond their domestic demand**, causing prices to crash across Asia.

This hit Thirumalai’s:

* PA margins
* Maleic margins
* Food acids margins
* Malaysia subsidiary performance

When China dumps excess chemicals, it becomes impossible for regional players to maintain normal margins.

# Storm 2: Dahej expansion temporarily created surplus in India.

Thirumalai added **90,000 tonnes** of new PA capacity in Dahej.  
Whenever a big plant starts up, the first year is always painful:

* Higher fixed costs
* Low utilisation
* Cheap selling to gain market share
* Lower production efficiency

The Chairman openly admits this: Dahej created temporary surplus and margins fell across the sector.

But he also states that:  
**“Ramp-up is now complete, and the plant should sell out within 18 months.”**

This is the classic capital cycle curve:  
**Pain first → then efficiency → then margins → then re-rating.**

# Storm 3: The Malaysia subsidiary became a drag.

The Malaysia plant (Optimistic Organic) was hit hardest by Chinese oversupply.  
Consolidated results show:

* Losses
* Higher working capital
* Poor spreads
* Rising risks

The Board is now reviewing “**all strategic options**”  meaning the company may sell, restructure, or wind down the unit.

If that happens, the single biggest drag on consolidated earnings disappears.

# 3 The Hidden Side of the Story  Why This Pain May Lead to Strength

TCL is currently in the **“darkest hour”** part of the capital cycle, where earnings are weak, interest costs spike, and investors panic.

But beneath the surface, **three positive forces** are building.

# Force 1: Dahej is now fully ramped.

The Dahej plant is one of the most efficient PA units in the world.  
Once utilisation rises from \~40–60% to 80–90%, the following happen:

* Cost per tonne drops sharply
* Energy integration kicks in
* Logistics advantage improves
* Operating leverage expands
* EBITDA/ROCE jump without extra capex

The Chairman calls Dahej:  
**“The largest single train unit in India and one of the largest in the world.”**

This is a future ROCE engine waiting to fire.

# Force 2: The US plant is strategically brilliant.

The US plant will serve the **world’s highest-margin region** for Maleic and food acids.

Key points from the Annual Report:

* Aimed at replacing US imports
* Margins in US remain strong despite global disruption
* Energy-efficient modular plant
* Expected revenue contribution from **2026**
* Built with Indian engineering → lower capex cost

Why this matters:  
US customers pay **premium prices** for stable, local, high-quality supply.  
Maleic imports into US face higher logistics and price volatility.

A domestic producer like TCL will command better spreads.

This is the **long-term multibagger trigger** in the story.

# Force 3: Industry consolidation will reduce Chinese pressure.

No country can dump unprofitably forever.  
Already, signs are emerging:

* Chinese producers cutting run-rates
* Global demand recovering slowly
* US anti-dumping noises increasing
* India’s domestic demand rising in plastics, paints, and coatings

TCL is a low-cost producer  these are the companies that survive downturns and thrive in upcycles.

# 4 What Investors Should Watch Next 

# 1) Dahej utilisation

The single most important metric.  
Once Dahej crosses **80% utilisation**, margins swing sharply.  
This usually appears in their quarterly production/operational commentary.

# 2) US plant commissioning

Watch for:

* Mechanical completion
* Trial runs
* First commercial dispatch
* Customer onboarding

Revenue starts **2026**.

# 3) Malaysia subsidiary outcome

If they:

* Sell it
* Shut part of it
* Find a partner
* Or write it down

→ consolidated profitability improves **instantly**.

# 4) Finance cost trend

Net debt rose to **₹1,349 crore** consolidated.  
Interest cost has doubled in the last year.  
As Dahej and US start contributing, this number must stabilise or decline.

# 5) Product spreads

Track:

* PA spreads vs o-xylene
* Maleic spreads in SE Asia
* Food acid spreads in US/EU

These are leading indicators of quarterly results.

# 5 So, Is Thirumalai Chemicals an Opportunity?

# Short-term (next 6–12 months):

Expect volatility.  
Results may remain soft.  
Margins may not immediately recover.

# Medium-term (12–36 months):

This is where things get interesting:

* Dahej fully utilised
* US margins highly accretive
* Malaysia outcome de-risked
* Debt starts reducing
* Capital cycle turns up
* Valuations re-rate

A company currently hurt by oversupply and capex could become, in two years, **one of the largest global producers of key acids with superior margins**.

# For a general reader:

Think of this as a company doing heavy lifting now  building big factories, suffering through a tough market  so that in a couple of years, when demand stabilises, it can earn much more money with the same assets.

This is why serious investors track such companies *before* the cycle turns.

Thirumalai Chemicals: A Turning-Point Story in India’s Chemical Cycle